normocalcaemic patients with secondary HPT baseline PTH, maximal and minimal PTH secretion and paraBackground. The regulation of PTH secretion by calcium is altered in patients with primary hyperparathy-thyroid gland size were reduced compared to 3-HPT patients. Compared to normal subjects, 2-HPT patients roidism (HPT ). A similar abnormality may occur in secondary HPT, but comparisons of PTH secretion in showed greater calcium-induced minimal PTH secretion. The increase in non-suppressible PTH secretion normal subjects and those with secondary HPT have given contrasting results. Differences in baseline serum resulted in a rightward shift of the PTH-ICa curve and an increase in the set point of ICa. A strong correlation ionized calcium (ICa) may partly account for these conflicting results. The aim of the present study was was found, in both primary and secondary HPT, between the set point of ICa and baseline serum ICa, to evaluate whether the regulation of PTH secretion by calcium differs from normal in patients with primary and between parathyroid gland size and baseline PTH, maximal PTH and minimal PTH. Multivariate regresand secondary HPT and to determine whether serum calcium concentration per se can affect the set point sion analysis showed that baseline serum ICa was the main determinant of the set point of ICa in both of calcium and the PTH-calcium relationship. Methods. The PTH-ICa relationship and the set point primary and secondary HPT.
The PTH-calcium curve in primary and secondary hyperparathyroidism 2399 serum calcium concentration: 16 normocalcaemic patients calcium triggering PTH secretion, whereas small (12 on haemodialysis, four on CAPD) were allocated in the increases reducing PTH release. To asses the secretory 2-HPT group, whereas 19 hypercalcaemic (ionized calcium behaviour of the parathyroids in humans, serum ion->1.28 mmol/l ) patients (14 on haemodialysis, five on ized calcium levels are raised by infusing calcium salts CAPD), were considered as affected by tertiary HPT and and lowered by infusing either sodium EDTA or citrate allocated in the 3-HPT group. All dialysis patients underwent to elicit reciprocal changes in serum PTH levels and a bone biopsy. The patients showed either mild lesions of obtain the sigmoidal PTH-calcium curve [2, 3] . In secondary HPT or overt osteitis fibrosa. None of the patients recent years, these dynamic tests of parathyroid gland had evidence of bone aluminum deposition as assessed by function have been widely used to examine the regula-histochemical staining and none were taking aluminumcontaining medications. Most of the dialysis patients had tion of PTH release by calcium in patients with either previously been treated with calcitriol, but vitamin D therapy primary or secondary hyperparathyroidism (HPT ), was discontinued for at least 1 month prior to study. The since in vitro studies on dispersed parathyroid cells patients affected by 1-HPT were hypercalcaemic and were have shown that alterations in the PTH release by studied before parathyroidectomy. All later had surgically calcium may contribute to excess PTH secretion either documented primary HPT, due to parathyroid adenoma, in primary or in secondary HPT [4, 5] .
with postoperative normalization of serum calcium levels.
In vivo studies have documented that the regulation Also 16 of 19 patients with 3-HPT and one patient with 2-of PTH secretion by calcium is altered in primary HPT HPT underwent total or subtotal parathyroidectomy after since the PTH-calcium curve is shifted to the right and parathyroid gland function was investigated by dynamic the set point for calcium is increased [6, 7] . On the tests. The patient with 2-HPT underwent parathyroidectomy because of very high PTH levels (805 pg/ml ) and calcaemia contrary, conflicting results have been reported in in in the upper normal range (1.26 mmol/l ).
vivo studies on uraemic patients, particularly with
The dynamic tests of parathyroid gland function were respect to set point for calcium. In fact, some authors performed in the 19 1-HPT, 16 2-HPT and 19 3-HPT patients did not find differences in set point values between by inducing acute changes in serum ionized calcium (ICa) in normal subjects and patients with secondary HPT [8, 9] order to maximally stimulate (PTH stimulation test) or or between uraemic patients with different degree of inhibit (PTH inhibition test) PTH secretion. Fourteen volunsecondary HPT [10] , while other authors documented teer subjects with normal renal function (N ) were also a rightward shift of the curve and the increase in the evaluated. In five patients with 1-HPT, the dynamic tests of set point with the worsening of secondary HPT [11] . parathyroid secretion were repeated when a stable reduction Moreover, Felsenfeld et al. [12, 13] found differences of serum ICa was achieved by pamidronate therapy Goodman et al. [14] did not show differences in patients within 3-7 days; dynamic parathyroid tests were calcium-sensing by parathyroids between dialysis performed after 2-4 days of stable ICa levels. The baseline patients with adynamic bone disease and those with characteristics and laboratory data of the patients are sumsecondary HPT. Indridason et al. [15] suggested that marized in Table 1 . parathyroid gland enlargement rather than calcium
The PTH stimulation test was performed by inducing sensing abnormalities plays a predominant role in PTH hypocalcaemia by infusing NaEDTA (20 mg/kg/h for hypersecretion in uraemic patients. Recent studies have 150 min). PTH inhibition test was performed, 1 week later, shown that the PTH-calcium curve and the set point by inducing hypercalcaemia by infusing CaCl 2 (4 mg/kg/h of elemental Ca for 150 min). PTH and ICa were determined of calcium can be modified by changes in baseline at baseline, and after 10, 20, 30 and 60 min and then every serum calcium [16, 17] , and this might explain, at least The goals of the present study were to: (i) evaluate 75 and 120 min and thereafter PTH levels remained stable whether the regulation of PTH secretion by calcium in or decreased. (ii) Maximal PTH inhibition (PTHmin), that patients with primary and secondary HPT differs from is the lowest level of PTH induced by hypercalcaemia; this normal; (ii) evaluate the relationship between the level was reached in all patients between 60 and 105 min and parathyroid gland mass, the alterations in calcium-thereafter PTH levels remained stable. (iii) The set point of mediated PTH secretion and the severity of HPT; calcium, which was calculated as either the ICa value at the midrange between PTHmin and PTHmax, as defined by (iii) determine whether serum calcium concentration Brown et al. [4] , or the ICa value at which PTHmax was per se can affect the set point of calcium and the PTHreduced by 50% [12] . The sensitivity of parathyroid cells to calcium relationship.
ICa variations was determined by calculating the slope of the sigmoidal curve, according to Messa et al. [9] . The PTHICa curves were constructed using PTHmax as 100% to Methods factor for differences in absolute PTH levels between the patients, and to provide an assessment of individual parathyroid cell function. From the data obtained by PTH We studied 19 patients with primary HPT (1-HPT ) and 35 stimulation and inhibition tests, individual PTH-ICa curves patients undergoing regular dialysis affected by secondary were constructed for each patient using both the four-HPT (PTH>200 pg/ml ). The uraemic patients were divided into two groups (2-HPT and 3-HPT ) according to baseline parameter model as described by Brown et al.
[4] and the polynomial regression analysis (Microsoft Excel 5.0 statistical expected baseline ICa, baseline PTH, PTHmax, package), as described elsewhere [18] . A fourth degree poly-PTHmin, and the serum ICa levels at which maximal nomial equation was used in the polynomial regression and minimal PTH secretion occurred were greater in analysis to describe the sigmoidal PTH-ICa relationship and 1-HPT than in N. Although 1-HPT patients displayed calculate the set point of calcium as 50% of PTHmax. a spectrum of PTH suppressibility, as a group, their Successful fits of the individual ICa-PTH data were achieved minimal PTH secretion induced by hypercalcaemia, in each patient (r ranging from 0.93 to 0.99, P<0.001).
evaluated as either absolute value ( 10-65 pg/ml ), ICa by using a selective ion electrode (ICA2 21±12%) was greater than in N (range: 6-13%, mean: Radiometer, normal: 1.15-1.28 mmol/l ). Parathyroid glands 8±2, P<0.001) (Figure 1 ). Moreover, minimal and were assessed by measuring the gland size at parathyroidec-maximal PTH secretion were achieved at greater ICa tomy, or by means of high-resolution color Doppler ultra-levels than in N. Thus, in 1-HPT the PTH-ICa curve, sonography performed with an Acuson XP10ART machine constructed using PTHmax as 100%, was shifted to (Acuson Corp, Maintainview, CA) using a 7.5 MHz linear the right and upward and the set point was increased phased array transducer. line serum ICa decreased from 1.45±0.04 to Results have been reported as means±SD. The data 1.25±0.06 mmol/l. The reduction of serum ICa stimuobtained were tested by Student's t test for paired or unpaired lated parathyroid gland and induced a significant data and by analysis of variance, as appropriate. Simple increase in baseline PTH and maximal PTH secretion linear regression was used to analyse the relationship between ( Table 3 ). The modifications of minimal PTH (as the set point of calcium and the slope of the PTH-ICa curve either absolute value or per cent of PTHmax) were not and gland volume, baseline serum ICa and phosphate, basesignificant. The ICa concentrations at maximal PTH line PTH, PTHmax and PTHmin. Multiple regression analysis was used to evaluate the factors that could affect the secretion and inhibition decreased. As a consequence set point of calcium and the slope of the PTH-ICa curve in of these secretory parameter changes, a leftward shift primary and in secondary HPT. For this analysis baseline of the PTH-ICa curve and a reduction of the set serum ICa, baseline PTH, serum phosphate, and parathyroid point of ICa were observed in these five patients after gland volume (measured by ultrasonography) were consid-the reduction in serum ICa levels. The decrease in the ered as independent variables. set point of ICa was directly correlated with the decrease in baseline serum ICa (y=0.9×+0.26, r= 0.82, P<0.05). The effect of serum ICa reduction on Results the sigmoidal PTH-ICa curve in one of our patients is reported in Figure 2 . Figure 3 shows the shift to the The parathyroid secretory parameters of patients with left of the composite regression line between probit 1-HPT, 2-HPT and 3-HPT compared to normal sub-PTH and ICa, after reduction of baseline serum ICa jects are reported in Table 2. in the five patients treated with pamidronate. The set point of ICa, calculated after probit transformation of Primary HPT (1-HPT) per cent PTH secretion, decreased from 1.42±0.05 to 1.19±0.07 mmol/l (P<0.05) after normalization of The volume of parathyroid adenoma ranged from 0.07 to 8.9 cm3, the gland weight from 0.05 to 14 g. As basal serum ICa. 1 . The set point of calcium (calculated as midpoint between maximal and minimal PTH secretion), the serum ICa at maximal PTH secretion and, the serum ICa at maximal PTH inhibition is reported for each individual patient affected by primary HPT (n=19, circles) and for 14 normal subjects (squares). Maximal PTH secretion is transformed to 100%. Polynomial regression analysis was used to calculate the curves. The sigmoidal curve is shifted to the right in primary HPT (dotted line, y=−63.6 x4+1202 x3 −4179 x2+5120 x −1981, r= 0.86) compared to normal subjects (thick line, y=−18604 x4+93286 x3−175638 x2+145334 x −44477, r=0.97).
Secondary HPT (2-HPT and 3-HPT)
2-and 3-HPT. Parathyroid gland volume ranged from 0.6 to 5.5 cm3 in 3-HPT and from 0.1 to 1.2 cm3 in 2-Patients with secondary HPT were divided into two HPT. The serum ICa levels at which maximal and groups according to serum ICa. Compared to N, minimal PTH secretion occurred and the minimal PTH normocalcaemic patients with secondary HPT (2-secretion induced by hypercalcaemia (as a per cent of HPT ) showed increased baseline, maximal and min-maximal PTH secretion) were greater than in N and imal PTH secretion ( Table 2 ). The increase in per cent 2-HPT. Thus, the PTH-ICa curve, constructed using minimal PTH secretion resulted in a rightward shift of PTHmax as 100%, was shifted to the right and upward the curve and an increase in the set point of ICa and the set point was increased in comparison to N in comparison to N (Table 2 and Figure 4) . Hyper-and 2-HPT ( Figure 4) . The slope of the curve calcaemic patients with secondary HPT (3-HPT ) had was significantly reduced in 3-HPT (range: greater parathyroid gland size, and greater baseline, 151-400%/mmol/l ), compared to N and 2-HPT HPT maximal and minimal PTH levels than 2-HPT ( Table (range: 270-652%/mmol/l ) ( Table 2) .
Compared to patients with 1-HPT, patients with 2). Serum phosphate was not significantly different in Table 3 . Effect of serum ionized calcium reduction by pamidronate significant correlation was also found between paratherapy on the PTH secretory parameters in five patients with thyroid gland volume and per cent minimal PTH (P<0.0002 and <0.00001), whereas the effect of baseline PTH, serum phosphate and parathyroid gland size was not statistically significant. The correlation hypercalcaemic secondary HPT (3-HPT ) showed between the set point of ICa and baseline ICa in greater baseline, minimal and maximal PTH levels, but patients with primary and secondary HPT is reported similar baseline ICa, ICamax, set point of ICa and in Figure 5 . The slope of the regression line between slope of the curve. Thus, the sigmoidal PTH-ICa curves serum ICa and set point of ICa was not different in were similar in 1-HPT and 3-HPT.
primary and secondary HPT, suggesting that the relationship between the set point of ICa and basal serum Correlation between parathyroid secretory parameters ICa is independent from the type of HPT. and other variables A significant negative linear correlation was found in secondary HPT between the slope of the PTH-ICa 4 . The set point of calcium (calculated as midpoint between maximal and minimal PTH secretion), the serum ICa at maximal PTH secretion and, the serum ICa at maximal PTH inhibition is reported for each individual patient affected by normocalcaemic (n=16, triangles) and hypercalcemic secondary HPT (n=19, asterisks) and, for 14 normal subjects (squares). Maximal PTH secretion is transformed to 100%. Polynomial regression analysis was used to calculate the curves. The sigmoidal curve is shifted to the right in hypercalcaemic secondary HPT (thin line, y=−6642 x4+37321 x3−77898 x2+71402 x −24131, r=0.92) compared to normocalcemic secondary HPT (dotted thick line, y=−15704 x4+81254 x3−156205 x2+131996 x −41251, r=0.94) and normal subjects (thick line, y=−18604 x4+93286 x3−175638 x2+145334 x −44477, r=0.97).
P<0.0001) showed that only baseline serum ICa was Discussion a significant (P<0.001) predictor. In primary HPT the slope of the PTH-ICa curve was correlated with base-The results of our study indicate that the regulation of line serum ICa (r=−0.45, P<0.05) and per cent PTH secretion by parathyroid glands, in response to changes in serum ICa, is altered in both primary and minimal PTH secretion (r=−0.58, P<0.01). secondary HPT. Previous in vitro and in vivo studies subjects, did not change significantly after the reduction of baseline serum ICa, suggesting that the sensitivity have documented that the set point of calcium and non-suppressible PTH secretion are greater in patients of parathyroid glands is altered in primary HPT within a wide range of baseline ICa concentrations. Thus, in with primary HPT than in normal subjects [4, 6 ] . In the present study we have evaluated in vivo the entire patients with primary HPT the combination of an increase in gland mass, a decrease in maximal PTH PTH-ICa curve by inducing maximal stimulation and inhibition of parathyroid gland; our results show that suppressibility, a decrease in parathyroid cell sensitivity, and an increase in the set point of ICa may in primary HPT patients there is not only an increase in the set point, but also a rightward shift of the curve contribute to inappropriate hypersecretion of PTH in face of hypercalcaemia, as supposed by Brown [4] . and a decrease in the slope of the curve, in comparison with normal subjects. PTH secretion in response to the To evaluate the dynamic of PTH secretion in secondary HPT we selected 35 dialysis patients with PTH increase in serum ICa was relatively non-suppressible and the degree of non-suppressibility (minimal PTH levels >200 pg/ml. The patients were divided into two groups according to baseline serum ICa. Calciumsecretion) correlated significantly with tumor mass, as reported also by Khosla et al. [6 ] . The reduction of mediated PTH suppression was significantly lower in normocalcaemic patients with secondary HPT (2-baseline serum ICa within the normal range by pamidronate therapy resulted in a shifted of the PTH-ICa HPT ) than in normal subjects, as reported also by others [8, 14, 15] . The consequent increase in per cent curve towards normal and in a reduction in the set point of ICa. The decrease in the set point of ICa was minimal PTH secretion resulted in a rightward shift of the PTH-ICa curve and an increase in the set point of directly correlated with the decrease in baseline serum ICa. However, the normalization of baseline serum ICa compared to normal subjects. Our data on the set point of calcium are in contrast with the results of ICa induced a significant increase in baseline PTH and maximal PTH secretion, whereas non-suppressible other studies [8] [9] [10] . Different criteria of selection of renal patients, as regards the degree of severity of PTH secretion remained greater than normal. Since, it is unlikely an increase in parathyroid mass after only secondary HPT and basal serum ICa levels can, at least partly, explain the divergent results. Messa et al. few days of relatively low serum ICa, we can speculate that the increase in PTH secretion is caused by an [9] studied renal patients with a GFR ranging between 12 and 60 ml/min. The patients showed a very mild increase in the per cent of active secretory cells. The activation of parathyroid cells after normalization of degree of HPT, since the mean basal PTH and maximal PTH in the subgroup of patients with advanced renal serum ICa is in agreement with the Parfitt's hypothesis that parathyroid cells in adenomas grow until the size failure were 142 and 312 pg/ml, respectively. The patients studied by Ramirez et al. [8] showed a degree of the gland is such that the amount of PTH secreted induces a degree of hypercalcaemia which meets 'the of secondary HPT very close to that of our normocalcaemic secondary HPT patients, as suggested by comparset point', so that a steady-state is achieved [20] . So, adenomatous parathyroid glands are 'set' to maintain able levels of baseline serum ICa, baseline PTH, and maximal and minimal PTH secretion. Also Ramirez et serum ICa at a constant, but higher, level than normal. Interestingly, the slope of the sigmoidal curve, that al. [8] documented an increase in non-suppressible PTH secretion in the patients with secondary HPT was reduced in primary HPT compared to normal
